Summit Therapeutics Inc. (SMMT)
Healthcare · Pharmaceutical Preparations
Summit Therapeutics Inc. (SMMT) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 3,489,224 | $59.02M | 0.44% |
| Candriam S.C.A. | 1,662,969 | $28.22M | 0.21% |
| Pictet Asset Management Holding SA | 1,121,137 | 8.77M | 0.14% |
| CITIGROUP INC | 510,193 | $8.63M | 0.06% |
| Simplify Asset Management Inc. | 510,106 | $8.63M | 0.06% |
| HOHIMER WEALTH MANAGEMENT, LLC | 441,650 | $7.47M | 0.06% |
| Bank of New York Mellon Corp | 425,443 | $7.19M | 0.05% |
| GRIFFIN ASSET MANAGEMENT, INC. | 324,017 | $5.48M | 0.04% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-06-12 | Zanganeh Mahkam | Co-Chief Executive Officer, Director, 10% Owner | Purchase | $49.99M |
| 2026-06-12 | DUGGAN ROBERT W | Co-Chief Executive Officer, Director, 10% Owner | Purchase | $49.99M |
| 2026-06-04 | DUGGAN ROBERT W | Co-Chief Executive Officer, Director, 10% Owner | Purchase | .46M |
| 2026-06-04 | Soni Manmeet Singh | COO and CFO, Director | Purchase | $360.8K |
| 2026-06-04 | Soni Manmeet Singh | COO and CFO, Director | Purchase | $361.5K |
| 2026-06-04 | Zanganeh Mahkam | Co-Chief Executive Officer, Director, 10% Owner | Purchase | .46M |
| 2025-10-21 | Xia Yu | Director | Purchase | 0.00M |
| 2025-10-21 | DUGGAN ROBERT W | Co-Chief Executive Officer, Director, 10% Owner | Purchase | $500.0K |